Seminars in Nuclear Medicine
Volume 37, Issue 1 , Pages 48-61 , January 2007

Single-Photon Emission Computed Tomography/Computed Tomography in Abdominal Diseases

References 

  1. Lucignani G. SPET: sustainable, powerful, effective, timely in vivo molecular imaging. Q J Nucl Med Mol Imaging. 2005;49:117–120
  2. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm. 2004;19:129–134
  3. Shreve PD. Adding structure to function. J Nucl Med. 2000;41:1380–1382
  4. von Schulthess GK. Integrated modality imaging with PET-CT and SPECT/CT: CT issues. Eur Radiol. 2005;15(suppl 4):D121–D126
  5. Cook GJR, Ott RJ. Dual-modality imaging. Eur Radiol. 2001;11:1857–1858
  6. von Schulthess GK, Pelc NJ. Integrated-modality imaging: the best of both words. Acad Radiol. 2002;9:1241–1244
  7. Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med. 2001;31:191–205
  8. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine–applications of dual-modality systems in oncology. Cancer Biother Radiopharm. 2004;19:1–10
  9. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging?. Eur J Nucl Med Mol Imaging. 2005;32:521–524
  10. Choi BY, Nguyen HM. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol. 2005;39:401–412
  11. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am. 1998;36:319–331
  12. Federle MP, Brancatelli G. Imaging of benign hepatic masses. Semin Liver Dis. 2001;21:237–249
  13. Horton KM, Bluemks DA, Hruban RH, et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics. 1999;19:431–451
  14. Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis. 2001;5:17–42
  15. Kammula US, Buell JF, Labow DM, et al. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001;30:141–146
  16. Jang HJ, Kim TK, Lim HK, et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol. 2003;180:135–141
  17. Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg. 2003;197:392–402
  18. Helmberger TK, Laubenberger J, Rummeny E, et al. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol. 2002;12:62–70
  19. Kim T, Federle MP, Baron RL, et al. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology. 2001;219:699–706
  20. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology. 2000;216:411–417
  21. Royal HD, Brown ML, Drum DE, et al. Procedure guideline for hepatic and splenic imaging (Society of Nuclear Medicine). J Nucl Med. 1998;39:1114–1116
  22. Ziessman HA, Silverman PM, Patterson J, et al. Improved detection of small cavernous hemangiomas of the liver with high resolution three-headed SPECT. J Nucl Med. 1991;32:2086–2091
  23. Scott AM, Macapinlac H, Zhang JJ, et al. Clinical applications of fusion imaging in oncology. Nucl Med Biol. 1994;21:775–784
  24. Birnbaum BA, Weinreb JC, Megibow AJ, et al. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology. 1990;176:95–101
  25. Birnbaum BA, Noz ME, Chapnick J, et al. Hepatic hemangiomas: diagnosis with fusion of MR, CT, and Tc-99m-labeled red blood cell SPECT images. Radiology. 1991;181:469–474
  26. Front D, Israel O, Groshar O, et al. Technetium-99m-labeled red blood cell imaging. Semin Nucl Med. 1984;14:226–250
  27. Maquire GQ, Noz ME, Rusinek H, et al. Graphics applied to medical image registration. IEE Compute Graphic Appl. 1991;11:20–28
  28. Martinez–Lazaro R, Dominguez P, Pascau J, et al. Usefulness of Tc-99m RBC SPECT/MRI fusion imaging in small suspected hepatic hemangiomas. Clin Nucl Med. 2004;29:844–845
  29. Desco M, Lopez J, Benito C, et al. A multimodality workstation in practice. In:  Lemke HU,  Vannier MW,  Inamura K, et al. editor. Computer Assisted Radiology and Surgery (CARS’99). Amsterdam: Elsevier Science; 1999;p. 218–222
  30. Hutton BF, Braun M, Thurfjell L, et al. Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging. 2002;29:559–577
  31. Patton JA, Delbeke D, Sandler MP. Image fusion using an integrated-dual-head coincidence camera with x-ray tube-based attenuation maps. J Nucl Med. 2000;41:1364–1368
  32. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med. 2000;27:619–627
  33. Schillaci O, Danieli R, Manni C, et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation?. Nucl Med Commun. 2004;25:705–710
  34. Schillaci O, Danieli R, Manni C, et al. Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging. 2004;31:1011–1015
  35. Zheng JG, Yao ZM, Shu CY, et al. Role of SPECT/CT in diagnosis of hepatic hemangiomas. World J Gastroenterol. 2005;11:5336–5341
  36. Romer W, Fiedler E, Pavel M, et al. Attenuation correction of SPECT images based on separately performed CT: effect on the measurement of regional uptake values. Nuklearmedizin. 2005;44:20–28
  37. Brancatelli G, Vilgrain V, Zappa M, et al. Case 80: splenosis. Radiology. 2005;234:1225–1229
  38. Fleming CR, Dickson ER, Harrison EG. Splenosis: autotransplantation of splenic tissue. Am J Med. 1976;61:414–419
  39. Horger M, Eschmann SM, Lengerke C, et al. Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography. Eur J Nucl Med Mol Imaging. 2003;30:316–319
  40. Livingstone CD, Levine BA, Lecklitner ML, et al. Incidence and function of residual splenic tissue following splenectomy for trauma in adults. Arch Surg. 1983;118:617–620
  41. Wedemeyer J, Gratz KF, Soudah B, et al. Splenosis—an important differential diagnosis in splenectomized patients presenting with abdominal masses of unknown origin. (in German) Z Gastroenterol. 2005;43:1225–1229
  42. Sikov WM, Schiffman FJ, Weaver M, et al. Splenosis presenting as occult gastrointestinal bleeding. Am J Hematol. 2000;65:56–61
  43. Tsiotos G, Schlinkert RT. Laparoscopic splenectomy for immune thrombocytopenic purpura. Arch Surg. 1997;132:642–646
  44. Castellani M, Cappellini M-D, Cappelletti M, et al. Tc-99m sulphur colloid scintigraphy in the assesment of residual splenic tissue after splenectomy. Clin Radiol. 2001;56:596–598
  45. Armas RR. Clinical studies with spleen-specific radiolabeled agents. Semin Nucl Med. 1985;15:260–275
  46. Gunes I, Yilmazlar T, Sarikaya I, et al. Scintigraphic detection of splenosis: superiority of tomographic selective spleen scintigraphy. Clin Radiol. 1994;49:115–117
  47. Franceschetto A, Casolo A, Cuccia M, et al. Splenosis: Tc-99m-labelled colloids provide the diagnosis in splenectomised patients. Eur J Nucl Med Mol Imaging. 2006;33:1102
  48. Massey MD, Stevens JS. Residual spleen found on denatured red blood cell scan following negative colloid scans. J Nucl Med. 1991;32:2286–2287
  49. Valdes Olmos RA, Horenblas S, Kartachova M, et al. 99mTc-labelled heat-denatured erythrocyte SPET-CT matching to differentiate accessory spleen from tumour recurrence. Eur J Nucl Med Mol Imaging. 2004;31:150
  50. Clarkson B, Young C, Dierick W, et al. Effects of continuous hepatic artery infusion of antimetabolities on primary and metastatic cancer of the liver. Cancer. 1962;15:472–488
  51. Cohen AD, Kemeny NE. An update on arterial infusion chemotherapy for colorectal cancer. Oncologist. 2003;8:553–566
  52. Lai YC, Shin CY, Jeng CM, et al. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein. World J Gastroenterol. 2003;9:2666–2670
  53. Barber FD, Mavligit G, Kurzrock R. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev. 2004;30:425–436
  54. Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs. 2004;15:439–452
  55. Kelly RJ, Kemeny NE, Leonard GD. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer. 2005;5:166–174
  56. Seki H, Kimura M, Yoshimura N, et al. Development of extrahepatic arterial blood supply to the liver during hepatic arterial blood supply to the liver during hepatic arterial infusion chemotherapy. Eur Radiol. 1998;8:1613–1618
  57. Pozniak MA, Bebel SG, Trump DL. Complications of hepatic arterial infusion chemotherapy. RadioGraphics. 1991;3:67–69
  58. Hohn DC, Stagg RJ, Price DC, et al. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2-deoxyurine. J Clin Oncol. 1985;3:1257–1260
  59. Pelosi E, Bar F, Battista S, et al. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a acintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol. 1999;44:505–510
  60. Lubin E, Cyjon A, Neuman M. Technetium-99m macroaggregates for the study of the distribution of arterial infusion chemotherapy in the liver. Clin Nucl Med. 1987;12:385–388
  61. Bledin AG, Kantarjian HM, Kim EE, et al. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. AJR Am J Roentgenol. 1982;139:711–715
  62. Gyves JW, Ziessman HA, Ensminger WD, et al. Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med. 1984;25:972–977
  63. Ziessman HA, Wahl RL, Juni JE, et al. The utility of SPECT for 99mTc-MAA hepatic arterial perfusion scintigraphy. AJR Am J Roentgenol. 1985;145:747–751
  64. Seki H, Kimura M, Kamura T, et al. Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: value of CT arteriography using an implantable port system. J Comput Assist Tomogr. 1996;20:343–348
  65. Denecke T, Hildebrandt B, Lehmkuhl L, et al. Fusion imaging using a hybrid SPECT/CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur J Nucl Med Mol Imaging. 2005;32:103–1010
  66. Ikeda O, Kusunoki S, Nakaura T, et al. Evaluation of fusion imaging using a combined spect/ct system; assessment of drug distribustion in patients whose catheter was fixed into a brunch of the hepatic aretry. (in Japanese) J Vasc Intervent Radiol. 2004;19:393–397
  67. Ikeda O, Kusunoki S, Nakaura T, et al. Comparison of fusion imaging using a combined SPECT/CT system and intra-arterial CT: assessment of drug distribution by an implantable port system in patients undergoing hepatic arterial infusion chemotherapy. Cardiovasc Intervent Radiol. 2006;29:371–379
  68. Martin-Comin J. Radiolabelled white blood cells in inflammatory bowel diseases. In:  Signore A,  Liberatore M,  Scopinaro F editor. Nuclear medicine in the management of inflammatory and infectious diseases. Berlin Heidelberg: Springer-Verlag; 2003;p. 31–39
  69. Gibson P, Lichtenstein M, Salehi N, et al. Values of positive technetium-99m leukocyte scans in predicting intestinal inflammation. Gut. 1991;32:1502–1507
  70. Lantto E, Jarvi K, Krekela I, et al. Technetium-99m hexamethyl propylene amine oxime leukocytes in the assessment of disease activity in inflammatory bowel disease. Eur J Nucl Med. 1992;19:14–18
  71. Roddie ME, Peters AM, Danpure HJ. Inflammation: imaging with Tc-99m HMPAO-labelled leukocytes. Radiology. 1988;166:767–772
  72. Stahlberg D, Veress B, Mare K, et al. Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histological assessment and Tc-99m-HMPAO labelled leukocyte scan. Am J Gastroenterol. 1997;92:283–288
  73. Weldon MJ, Joseph AEA, Maxwell JD. Single photon emission computerised tomography (SPECT):A novel technique for imaging inflammatory bowel disease. (abstr) Gut. 1992;33:S3
  74. Weldon MJ, Masoomi AM, Britten AJ, et al. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut. 1995;36:243–250
  75. Charron M, del Rosario FJ, Kochoshis SA. Pediatric inflammatory bowel disease: assessment with scintigraphy with 99Tc white blood cells. Radiology. 1999;212:507–513
  76. Biancone L, Schillaci O, Capoccetti F, et al. Technetium-99m–HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn’s disease extent and intestinal infiltration. Am J Gastroenterol. 2005;100:344–354
  77. Biancone L, Scopinaro F, Ierardi M, et al. 99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn’s Disease. Dig Dis Sci. 1997;42:1549–1556
  78. Kaplan IL, Swayne LC. Composite SPECT/CT images: technique and potential applications in chest and abdominal imaging. AJR Am J Roentgenol. 1999;152:865–866
  79. Swayne LC. Computer-assisted fusion of single-photon emission tomographic and computed tomographic images (Evaluation in complicated inflammatory disease). Invest Radiol. 1992;27:78–83
  80. Mirtcheva RM, Kostakoglu L, Goldsmith SJ. SPECT+CT fusion imaging in 111In WBC scintigraphy. (abst) J Nucl Med. 2003;44:341P–342P
  81. Filippi L, Biancone L, Petruzziello C. Tc-99m HMPAO labelled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Chron’s disease. Clin Nucl Med. 2006;31:541–542
  82. Filippi L, Petruzziello C, Barone R, et al: Imaging Chron’s disease by 99mTc-HMPAO-labeled leukocyte: usefulness of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging (abstr) (in press)
  83. Goerres GW. SPECT/CT in non-malignant disease. In:  von Schulthess GK editors. Clinical molecular anatomic imaging. Philadelphia: Lippincott Williams & Wilkins; 2003;p. 463–467
  84. Winzelberg GG, Froelich JW, McKusick KA, et al. Scintigraphic detection of gastrointestinal bleeding: a review of current methods. Am J Gastroenterol. 1983;78:324–327
  85. Howart DM, Tang K, Lees W. The clinical utility of nuclear medicine imaging for the detection of occult gastrointestinal haemorrhage. Nucl Med Commun. 2002;23:591–594
  86. Ford PV, Bartold SP, Fink-Bennett DM, et al. Procedure guideline for gastrointestinal bleeding and Meckel’s diverticulum scintigraphy (Society of Nuclear Medicine). J Nucl Med. 1999;40:1226–1232
  87. Zuckier LS. Acute gastrointestinal bleeding. Semin Nucl Med. 2003;33:297–311
  88. Marignani M, Angeletti S, Filippi L, et al. Occult and obscure bleeding, iron deficiency anemia and other gastrointestinal stories. Int J Mol Med. 2005;15:129–135
  89. Howart DM. The role of nuclear medicine in the detection of acute gastrointestinal bleeding. Semin Nucl Med. 2006;36:133–146
  90. Yama N, Ezoe E, Kimura Y, et al. Localization of intestinal bleeding using a fusion of Tc-99m-labeled RBC SPECT and x-ray CT. Clin Nucl Med. 2005;30:488–489
  91. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging. 2004;17:205–216

PII: S0001-2998(06)00054-7

doi: 10.1053/j.semnuclmed.2006.07.001

Seminars in Nuclear Medicine
Volume 37, Issue 1 , Pages 48-61 , January 2007

Article Tools

* Image Usage & Resolution